ArticleJournal of the American Academy of Dermatology2022

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.

Shannon Wongvibulsin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.